Skip to content
Open in App
Advanced Biomed logo

Advanced Biomed

web2

Advanced Biomed is a holding company developing artificial intelligence software for checking f...

Symbol ยท ADVB
Company profile

About

Advanced Biomed is a holding company developing artificial intelligence software for checking financial information against underlying documents and rules through its Hong Kong technology subsidiary. Its principal product, FinTruth, is designed to verify financial analyses and AI-generated content and produce traceable results for enterprise users. The company acquired Acellent Technologies in April 2026 and shifted away from its former biotechnology business. It sold its previous subsidiaries engaged in microfluidic technology and cancer screening development during 2025 and 2026. FinTruth remains at an early commercialization stage, with pilot discussions underway and no customer revenue from the product reported in its latest annual filing.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeNasdaqPrimary symbol: ADVB
Expert coverage

Advanced Biomed profile.

Orbitrum research

Expert coverage

No published expert evaluations are available for this project yet.

Orbitrum Academy

Learn how to read a project assessment